Figure 2. Current American Heart Association/American College of Cardiology guideline recommendations for lipid‐lowering therapy in patients with acute coronary syndrome (ACS).

*Recommendations for very‐high‐risk patients, defined as a history of multiple atherosclerotic cardiovascular disease events or 1 major atherosclerotic cardiovascular disease event and multiple high‐risk conditions, including aged ≥65 years, heterozygous familial hypercholesterolemia, diabetes mellitus, hypertension, smoking, and history of congestive heart failure. ^†High‐intensity statin includes atorvastatin, 40 to 80 mg/d, or rosuvastatin, 20 to 40 mg/d. LDL‐C indicates low‐density lipoprotein cholesterol; and PCSK9, proprotein convertase subtilisin/kexin type 9.